Director Drug Development
Anna Sandholm holds a PhD in Environmental Chemistry from Stockholm University, in the scientific area of Drug Metabolism and Pharmacokinetics. Anna has extensive experience from the pharmaceutical industry and from academic research.
Anna has worked extensively with candidate drug selection and early-to-late drug development across a broad range of indications. She has significant knowledge of regulatory guidelines and recommendations, and a solid understanding of how to best apply them while maintaining focus on the overall scientific rationale.
Her core competence is nonclinical and early clinical projects from a scientific, strategic and regulatory perspective. She has worked at SDS since 2012, primarily as a senior consultant in drug development and as Director for SDS Nonclinical and DMPK.
phone + 46 70 582 98 14